KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) Other Operating Expenses (2016 - 2025)

Hologic's Other Operating Expenses history spans 17 years, with the latest figure at $130.9 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $130.9 million; the TTM value through Dec 2025 reached $130.9 million, up 7600.0%, while the annual FY2023 figure was -$51.7 million, 30.89% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $130.9 million at Hologic, up from $1.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $130.9 million in Q4 2025 and bottomed at -$79.0 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $2.9 million (2021), against an average of $5.1 million.
  • The largest YoY upside for Other Operating Expenses was 2840.0% in 2021 against a maximum downside of 3500.0% in 2021.
  • A 5-year view of Other Operating Expenses shows it stood at $4.1 million in 2021, then tumbled by 2026.83% to -$79.0 million in 2022, then soared by 97.85% to -$1.7 million in 2023, then skyrocketed by 200.0% to $1.7 million in 2024, then surged by 7600.0% to $130.9 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Other Operating Expenses are $130.9 million (Q4 2025), $1.7 million (Q3 2024), and -$1.7 million (Q4 2023).